Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 40 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

95%

38 trials in Phase 3/4

Results Transparency

94%

33 of 35 completed trials have results

Key Signals

3 recruiting33 with results

Enrollment Performance

Analytics

Phase 3

24(63.2%)

Phase 4

14(36.8%)

38Total

Phase 3(24)

Phase 4(14)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials

NCT06901297Phase 3Recruiting

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

Role: lead

NCT06715891Phase 3Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Role: lead

NCT07171099Phase 3Recruiting

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

Role: lead

NCT06284265Phase 3Active Not Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Role: lead

NCT06263881Phase 3Completed

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

Role: lead

NCT05364671Phase 3Completed

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Role: lead

NCT05069649Phase 3Completed

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

Role: lead

NCT04295681Phase 3Completed

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

Role: lead

NCT04552041Phase 3Completed

Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.

Role: lead

NCT04918771Phase 3Completed

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Role: lead

NCT05074888Phase 3Completed

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Role: lead

NCT04569357Phase 3Completed

Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Role: lead

NCT03159104Phase 3Completed

Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children

Role: lead

NCT04250311Phase 3Suspended

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

Role: lead

NCT05605938Phase 4Completed

Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders

Role: lead

NCT03119766Phase 4Completed

Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

Role: lead

NCT04244084Phase 3Completed

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

Role: lead

NCT03039621Phase 4Completed

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Role: lead

NCT03485495Phase 4Completed

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

Role: lead

NCT01570829Phase 3Completed

Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients

Role: lead